The T1D Exchange Registry

Diabetes Clinical Trial

— T1D Registry  

Official title:

The T1D Exchange Registry

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04629586
• Other study ID #: 1822333
• Status: Recruiting
• Start date: December 13, 2018
• Est. completion date: December 31, 2030

Study information

• Verified date: May 2023
• Source: T1D Exchange, United States
• Contact: Kelsie LaFerrier
• Phone: (617) 892-9941
• Email: klaferriere[@]t1dexchange.org
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The T1D Exchange Registry is a research study, conducted over time, for individuals with type 1 diabetes and their supporters. Participants volunteer to provide their data for research (for example, by answering questions in annual surveys). Once enrolled, Registry participants have the opportunity to sign up for other studies on various topics related to type 1 diabetes.

To participate, you will be asked to:

• Read and sign an online informed consent form

• Take a survey describing specific demographic and type 1 diabetes management information

• Update your information annually

• Periodically opt in for additional research opportunities (if you choose), i.e. taking new surveys or uploading health device data

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 50000
• Est. completion date: December 31, 2030
• Est. primary completion date: December 31, 2030
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Clinical diagnosis of type 1 diabetes.

• Individuals younger than 18 years of age must have parent/guardian consent.

• Must be able to read and understand English.

• Currently living in the United States

Exclusion criteria:

• Does not use insulin and has not had a pancreatic or islet cell transplant.

• Cannot fully read and understand English.

• Does not currently live in the United States.

Related Conditions & MeSH terms

• Diabetes
• Diabetes Mellitus
• Diabetes Mellitus, Type 1
• Type 1 Diabetes

Intervention

Other:
• No intervention
Observational research study

Locations

Country	Name	City	State
United States	T1D Exchange	Boston	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
T1D Exchange, United States

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Gather longitudinal data from individuals living with type 1 diabetes.	Gather longitudinal data on disease, health status, and patient-reported outcomes of individuals living with type 1 diabetes. This will be achieved by presenting participants with annual questionnaires, tracking any changes in their responses over time.	10 years